Vect-Horus

Vect-Horus is a biotechnology company headquartered in Marseille, France, dedicated to the design and development of carriers that can specifically deliver therapeutic molecules and imaging agents. Together with its co-development partner, RadioMedix (a Houston, U.S.-based company specializing in nuclear medicine), Vect-Horus is preparing the pre-IND dossier for its Theragnostic agent for clinical diagnosis of glioblastoma in 2021. Finally, several collaboration agreements have been signed or are under negotiation with various pharmaceutical partners. The company aims to strike a balance between advancing its R&D programs and generating increasing revenue from these industry partnerships.